FTC Approves Final Order Imposing Conditions on Stryker Corp.’s Acquisition of Wright Medical Group N.V.

Federal Trade Commission

WASHINGTON, D.C. — Following a public comment period, the Federal Trade Commission recently approved a final order settling charges that medical device company Stryker Corp.’s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.

According to the complaint, which was first announced in November 2020, the proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.

Commission staff and the staff of the UK Competition and Markets Authority worked cooperatively to analyze the proposed transaction and potential remedies.

The final order requires Stryker and Wright to divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. The Commission vote to approve the final order was 5-0.

READ:  FTC Requires Mobile Advertising Company to Stop Misleading Users About In-Game Rewards

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments